Real time mobile AI-assisted Cervicography interpretation System

In our opinion, the TeleOTIVA application is very convenient, practical, and easy to use. We immediately get screening results validated by an obgyn specialist. This really helps us as midwives in our work and provides more accurate results, thus satisfying us and the patients.

This application is very useful for health workers, especially to make it easier to get positive or negative IVA test results directly. So far, results have only been obtained through direct observation by specialist doctors and take a long time. With TeleOTIVA, the results are more accurate and can be directly validated by obgyn specialists quickly and accurately.

TeleOTIVA is very useful for midwives, health centers, and hospitals because it helps the screening process for cervical precancer, which is a serious threat to women. With this application, medical personnel can conduct screening quickly and accurately, and the results are validated by obgyn specialists.

In my opinion, this is one of the very good innovations. In the digital era like today, detecting a disease can be converted and studied by AI in a real and accurate way. With this application, we as medical personnel feel very helped because the application is very easy.

It is very easy to use, just by taking a photo in real-time, the results are immediately readable and more accurate because they are validated by obgyn specialists, both obgyn specialists here and at Palembang General Hospital.

As a nurse, I feel that this application is very helpful in IVA examination. With this application, we as health workers can find out the results of the examination more quickly and accurately. We hope that TeleOTIVA can continue to be used in every IVA examination service so that its benefits are increasingly felt by the wider community.

After being introduced to this application, I think it is quite good. With real-time AI prediction, TeleOTIVA can help screen positive and negative IVA cases. Hopefully, this application can later be used in the national screening program in Indonesia.

We welcome the commercialization plan of the TeleOTIVA version 2.0 application. This application is expected to be a bridge for the community to obtain consultation services and health monitoring more efficiently. Hopefully, TeleOTIVA version 2.0 can continue to develop and become an integral part of the health program in South Sumatra.